Medicare Coverage Confirmation
Medicare administrative contractors confirmed continued Medicare coverage for cataract surgery procedures performed with a single MIGS procedure, which is crucial for the growth of the surgical glaucoma franchise.
TearCare's Strong Demand
Higher dry eye revenue was driven by demand for TearCare/Smart Lids ahead of a price increase, highlighting significant interest in TearCare as a compelling solution for dry eye patients.
Reduction in Net Loss
The net loss for the third quarter was $11.1 million or $0.22 per share, compared to a net loss of $13 million or $0.27 per share for the third quarter of 2023, indicating improved financial discipline.
Organizational Enhancements
Key organizational changes were made to enhance execution and performance consistency across territories, aiming for better commercial execution.
Cash Flow Improvements
Generated $0.4 million of cash in the quarter, a significant improvement compared to $10 million of cash used in the third quarter of 2023.